Anavex Life Sciences
AVXL
#7563
Rank
S$0.50 B
Marketcap
S$5.70
Share price
-1.12%
Change (1 day)
-43.95%
Change (1 year)

Anavex Life Sciences (AVXL) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : S$14.86 Million

According to Anavex Life Sciences 's latest financial reports the company's total liabilities are S$14.86 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Anavex Life Sciences - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30S$19.66 M14.86%
2023-09-30S$17.12 M16.79%
2022-09-30S$14.66 M-0.04%
2021-09-30S$14.66 M47.11%
2020-09-30S$9.96 M43.13%
2019-09-30S$6.96 M31.14%
2018-09-30S$5.31 M9.03%
2017-09-30S$4.87 M11.92%
2016-09-30S$4.35 M14.92%
2015-09-30S$3.78 M-58.54%
2014-09-30S$9.13 M154.82%
2013-09-30S$3.58 M1.01%
2012-09-30S$3.54 M103.12%
2011-09-30S$1.74 M-59.62%
2010-09-30S$4.32 M-28.34%
2009-09-30S$6.03 M82.78%
2008-09-30S$3.3 M383.87%
2007-09-30S$0.68 M1435.37%
2006-09-30S$0.04 M-2.53%
2005-09-30S$0.04 M983.75%
2004-09-30S$0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ligand Pharmaceuticals
LGND
S$0.68 B 4,489.52%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S$1.08 B 7,171.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
S$0.24 B 1,570.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
S$13.1 M-11.84%๐Ÿ‡บ๐Ÿ‡ธ USA